Opportunity Information: Apply for PAR 25 240

The Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) funding opportunity (PAR-25-240) is a National Institutes of Health (NIH) grant program designed to support U.S.-focused policy research that can reduce disparities in exposure to and use of tobacco, alcohol, and cannabis. The core idea is to fund studies that evaluate new policies or modifications to existing policies and to measure how those policy changes affect substance use patterns and secondhand exposure, especially in communities that experience disproportionate health burdens. The emphasis is not only on whether a policy "works" on average, but on whether it narrows or widens inequities and how it changes cancer prevention-relevant risks across different populations.

A central requirement of the program is authentic engagement with one or more community organizations. This is meant to ensure the research is grounded in real community priorities, improves the relevance and interpretation of findings, and helps position the work to translate into practical, equitable policy solutions. In other words, the program is looking for projects that do more than analyze laws on paper; it wants research that connects policy design and implementation to lived experience, real-world enforcement, access, marketing environments, and downstream health-related outcomes tied to cancer prevention.

The opportunity supports research on policies related to tobacco, alcohol, and/or cannabis, either individually or in combination. Projects can examine policies that are brand new, recently implemented, or adapted in response to changing product landscapes and legal environments. The outcomes of interest include substance use behaviors and secondhand exposure, with a clear equity lens: applicants should focus on populations experiencing disparities and explicitly examine differential impacts by group, place, or structural conditions that shape risk. The long-term goal stated in the announcement is to build a stronger evidence base for policy approaches that improve health equity and advance cancer prevention by reducing harmful use and exposure.

This is an R01 grant mechanism with "Clinical Trial Optional" indicated, meaning applicants may propose studies that include clinical trials if appropriate, but clinical trials are not required. The award ceiling listed is $500,000, and the opportunity remains open with an original closing date of January 7, 2028, indicating multiple submission cycles may be available during the open period (as is common with NIH program announcements).

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); Native American tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

The program has clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply under this announcement. In practical terms, the applicant organization and the work proposed under the grant should be domestic and structured to comply with these limits.

From an administrative standpoint, this is a discretionary grant in the NIH portfolio, categorized under education and health funding activities, and associated with CFDA numbers 93.273, 93.279, 93.307, 93.393, and 93.399. Overall, the opportunity is aimed at teams that can bring together policy analysis, rigorous research methods, and meaningful community partnership to produce actionable evidence on how tobacco, alcohol, and cannabis policies can be designed and implemented in ways that reduce disparities and support equitable cancer prevention outcomes.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273, 93.279, 93.307, 93.393, 93.399.
  • This funding opportunity was created on 2024-11-13.
  • Applicants must submit their applications by 2028-01-07.
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 240

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: FY25 IIJA/IRA Bureau of Land Management Idaho (ID) Threatened and Endangered Species Program

Previous opportunity: Bipartisan Infrastructure Law – San Francisco Bay Water Quality Improvement Fund

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 240

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 240) also looked into and applied for these:

Funding Opportunity
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) Apply for PAR 25 255

Funding Number: PAR 25 255
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 25 256

Funding Number: PAR 25 256
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 25 072

Funding Number: PAR 25 072
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Apply for PAR 25 094

Funding Number: PAR 25 094
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) Apply for PAR 24 316

Funding Number: PAR 24 316
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) Apply for PAR 25 204

Funding Number: PAR 25 204
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional) Apply for PAR 25 152

Funding Number: PAR 25 152
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 25 244

Funding Number: PAR 25 244
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Apply for PAR 25 243

Funding Number: PAR 25 243
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) Apply for PAR 25 229

Funding Number: PAR 25 229
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 25 228

Funding Number: PAR 25 228
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 25 096

Funding Number: PAR 25 096
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 25 095

Funding Number: PAR 25 095
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 25 124

Funding Number: PAR 25 124
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 25 070

Funding Number: PAR 25 070
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 25 069

Funding Number: PAR 25 069
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Apply for RFA HG 25 003

Funding Number: RFA HG 25 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 25 275

Funding Number: PAR 25 275
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 25 002

Funding Number: RFA HG 25 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 25 129

Funding Number: PAR 25 129
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 240", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: